Precursor B Lymphoblastic Leukemia with Surface Light Chain Immunoglobulin Restriction: A Report of 15 Patients

American Journal of Clinical Pathology

Volumn 121, Issue 4, 2004, Pages 512-525

  Kansal, Rina ^a,c   Deeb, George ^a   Barcos, Maurice ^b   Wetzler, Meir ^b   Brecher, Martin L ^b   Block, AnneMarie W ^b   Stewart, Carleton C ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Acute lymphoblastic leukemia; Flow cytometry; Immunophenotyping; Precursor B cell; Surface immunoglobulin positive acute leukemia; WHO classification

Indexed keywords

CD19 ANTIGEN; CD34 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; DNA NUCLEOTIDYLEXOTRANSFERASE; IMMUNOGLOBULIN D; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B CELL LEUKEMIA; BLAST CELL; CANCER CLASSIFICATION; CANCER RECURRENCE; CHILD; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; DIPLOIDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; KARYOTYPE; LYMPHATIC LEUKEMIA; MALE; PHENOTYPE; PRIORITY JOURNAL;

EID: 1642400281     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/WTXCQ5NRACVXTYBY     Document Type: Article

References (40)

1. Jaffe ES, Harris NL, Stein H, et al, eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissue. Lyon, France: IARC Press; 2001:109-187. World Health Organization Classification of Tumours.
2. Jennings CD, Foon KA. Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy. Blood. 1997;90:2863-2892.
3. Foon KA, Todd RF. Immunologic classification of leukemia and lymphoma. Blood. 1986;68:1-31.
4. Koehler M, Behm FG, Shuster J, et al. Transitional pre-B-cell acute lymphoblastic leukemia of childhood is associated with favorable prognostic clinical features and an excellent outcome: a Pediatric Oncology Group study. Leukemia. 1993;7:2064-2068.
5. Behm FG, Head DR, Pui C-H, et al. B-precursor ALL with unexpected expression of surface immunoglobulin (sIg) mu and lambda [abstract]. Lab Invest. 1995;72:106A.
6. Michiels JJ, Adriaansen HJ, Hagemeijer A, et al. TdT positive B-cell acute lymphoblastic leukemia (B-ALL) without Burkitt characteristics. Br J Haematol. 1988;68:423-426.
7. Vasef MA, Brynes RK, Murata-Collins JL, et al. Surface immunoglobulin light chain-positive acute lymphoblastic leukemia of FAB L1 or L2 type: a report of 6 cases in adults. Am J Clin Pathol. 1998;110:143-149.
8. Stewart CC, Stewart SJ. Cell preparation for the identification of leukocytes. In: Darzynkiewicz Z, Crissman H, Robinson JP, eds. Methods in Cell Biology. New York, NY: Academic Press; 2001:218-270.
9. Stewart CC, Stewart SJ. Multiparameter data acquisition and analysis of leukocytes by flow cytometry. In: Darzynkiewicz Z, Crissman H, Robinson JP, eds. Methods in Cell Biology. New York, NY: Academic Press; 2001:289-312.
10. Riedy MC, Muirhead KA, Jensen CP, et al. Use of a photolabeling technique to identify nonviable cells in fixed homologous or heterologous cell populations. Cytometry. 1991;12:133-139.
11. Bennett JM, Catovsky D, Daniel M-T, et al, for the French-American-British (FAB) co-operative group. Proposals for the classification of acute leukemias. Br J Haematol. 1976;33:451-458.
12. Griffith RC, Kelly DR, Nathwani BN, et al. A morphologic study of childhood lymphoma of the lymphoblastic type: the Pediatric Oncology Group experience. Cancer. 1987;59:1126-1131.
13. Chilosi M, Pizzolo G. Review of terminal deoxynucleotidyl transferase: biological aspects, methods of detection, and selected diagnostic applications. Appl Immunohistochem. 1995;3:209-221.
14. Yunis JJ. New chromosome techniques in the study of human neoplasia. Hum Pathol. 1981;12:540-549.
15. Mitelman F, ed. ISCN 1995: An International System for Human Cytogenetic Nomenclature 1995. Basel, Switzerland: S Karger; 1995.
16. Rubnitz JE, Downing JR, Pui C-H, et al. TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significance. J Clin Oncol. 1997;15:1150-1157.
17. Crist W, Carroll A, Shuster J, et al. Philadelphia chromosome positive acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome: a Pediatric Oncology Group study. Blood. 1990;76:489-494.
18. Pui C-H, Crist WM, Look AT. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood. 1990;76:1449-1463.
19. Raimondi SC, Behm FG, Roberson PK, et al. Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19). J Clin Oncol. 1990;8:1380-1388.
20. Borowitz MJ, Hunger SP, Carroll AJ, et al. Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis: a Pediatric Oncology Group study. Blood. 1993;82;1086-1091.
21. Silverman LB, Sallan SE. Acute lymphoblastic leukemia. In: Handin RI, Lux SE, Thomas P, eds. Blood: Principles and Practice of Hematology. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2003:779-804.
22. Hammami A, Chan WC, Michels SD, et al. Mature B-cell acute leukemia: a clinical morphological, immunological, and cytogenetic study of nine cases. Hematol Pathol. 1991;5:109-118.
23. Navid F, Mosijczuk AD, Head DR, et al. Acute lymphoblastic leukemia with the (8;14)(q24;q23) translocation and FAB L3 morphology associated with a precursor immunophenotype: the Pediatric Oncology Group experience. Leukemia. 1999;13:135-141.
24. Drexler HG, Messmore HL, Menon M, et al. A case of TdT-positive B-cell acute lymphoblastic leukemia. Am J Clin Pathol. 1986;85:735-738.
25. Secker-Walker L, Stewart E, Norton J, et al. Multiple chromosome abnormalities in a drug resistant TdT positive B-cell leukemia. Leuk Res. 1987;11:155-161.
26. Shende A, Festa RS, Wedgwood JF, et al. A paediatric case of a TdT positive B-cell acute lymphoblastic leukaemia (B-ALL) without Burkitt characteristics [letter]. Br J Haematol. 1988;70:129-130.
27. Oshimura M, Freeman AI, Sandberg AA. Chromosomes and causation of human cancer and leukemia, XXVI: banding studies in acute lymphoblastic leukemia (ALL). Cancer. 1977;40:1161-1172.
28. Palka G, Fioritoni G, Lambardo M, et al. A cytogenetic survey of 13 patients with acute lymphocytic leukemia (ALL). Hematologica. 1987;72:511-514.
29. Matutes E, Oscier D, Garcia-Marco J, et al. Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients. Br J Haematol. 1996;92:382-388.
30. Rimsza LM, Larson RS, Winter SS, et al. Benign hematogone-rich lymphoid proliferations can be distinguished from B-lineage acute lymphoblastic leukemia by integration of morphology, immunophenotype, adhesion molecule expression, and architectural features. Am J Clin Pathol. 2000;114:66-75.
31. McKenna RW, Washington LT, Aquino DB, et al. Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry. Blood. 2001;98:2498-2507.
32. Loken MR, Shah VO, Dattilio KL, et al. Flow cytometric analysis of human bone marrow, II: normal B lymphocyte development. Blood. 1987;70:1316-1324.
33. Anderson KC, Bates MP, Slaughenhoupt BL, et al. Expression of human B-cell associated antigens on leukemias and lymphomas: a model of human B cell differentiation. Blood. 1984;63:1424-1433.
34. Hurwitz C, Loken MR, Graham ML, et al. Asynchronous antigen expression in B lineage acute lymphoblastic leukemia. Blood. 1988;72:299-307.
35. Boue DR, LeBien TW. Expression and structure of CD22 in acute leukemia. Blood. 1988;71:1480-1486.
36. Dorvault CC, Jones PA, Swerdlow SH, et al. Frequent cell surface expression of CD22 on B-lineage acute lymphoblastic leukemias (ALL) [abstract]. Lab Invest. 1999;79:135A.
37. Siebert JD, Katzke KA, Copp MV, et al. Cell surface CD22 is commonly expressed in precursor B-lymphoblastic leukemia [abstract]. Am J Clin Pathol. 2001;116:606.
38. Ciudad J, San Miguel JF, Lopez-Berges MC, et al. Detection of abnormalities in B-cell differentiation pattern is a useful tool to predict relapse in precursor-B-ALL. Br J Haematol. 1999;104:695-705.
39. Weir EG, Cowan K, LeBeau P, et al. A limited antibody panel can distinguish B-precursor acute lymphoblastic leukemia from normal B precursors with four-color flow cytometry: implications for residual disease detection. Leukemia. 1999;13:558-567.
40. Soslow RA, Zukerberg LR, Harris NL, et al. bcl-1 (PRAD-1/cyclin D-1) overexpression distinguishes the blastoid variant of mantle cell lymphoma from B-lineage lymphoblastic lymphoma. Mod Pathol. 1997;10:810-817.